Cell MedX Corp. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q2 2017 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
Cell MedX Corp. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q2 2017 to Q3 2024.
- Cell MedX Corp. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending August 31, 2024 was -$909K, a 63.2% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)